Free Trial
→ When This Happens, You Don’t Wait. You Act. (From Crypto Swap Profits) (Ad)
OTCMKTS:BETRF

BetterLife Pharma 5/29/2024 Earnings Report

BetterLife Pharma logo
$0.07 0.00 (0.00%)
As of 06/13/2025
ProfileEarnings History

BetterLife Pharma EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BetterLife Pharma Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BetterLife Pharma Announcement Details

Quarter
Date
5/29/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

BetterLife Pharma's next earnings date is estimated for Wednesday, June 25, 2025, based on past reporting schedules.

Conference Call Resources

BetterLife Pharma Earnings Headlines

BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
May 28, 2025 | finance.yahoo.com
BetterLife Pharma Inc.: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 15, 2025 | finanznachrichten.de
[Wanted] 250 intrepid souls
He Called this 106X Opportunity Before Reddit… and Before Elon Musk Before GameStop rocketed up to 10,633, Jonathan Rose saw something strange: A sudden surge in options volume — thousands of contracts flooding in. The money hit deep inside the CBOE before Reddit posts created the short squeeze and before Elon's tweet sent GameStop flying. Jonathan calls it the "Big-Money Tell," and it's flagged dozens of big trade opportunities including: 462.5% in C3.ai, 245.13% in Criteo, and 39.46% in Roku. And these are just some of the gains the "tell" has identified. Even better: He says the next big set-up could be forming right now. And there's still time for you to get in before it kicks off as soon as seven days from now.
June 14, 2025 | Masters in Trading (Ad)
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 14, 2025 | globenewswire.com
BetterLife Pharma Inc.: BetterLife Announces Debt Settlements
May 10, 2025 | finanznachrichten.de
BetterLife Announces Debt Settlements
May 6, 2025 | globenewswire.com
See More BetterLife Pharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BetterLife Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BetterLife Pharma and other key companies, straight to your email.

About BetterLife Pharma

BetterLife Pharma (OTCMKTS:BETRF), a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

View BetterLife Pharma Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles